Natriuretic peptides, brain (B-type) natriuretic peptide (BNP) and N-terminal prohormone of
brain natriuretic peptide (NT-proBNP) are globally and most often used for the diagnosis of …

Heart failure (HF) with preserved ejection fraction (HFpEF) is a global health care problem,
with diagnostic difficulty, limited treatment options and high morbidity and mortality rates …

Background US guidelines recommend consideration of sacubitril/valsartan in chronic heart
failure (HF) and mildly reduced or preserved ejection fraction (EF). Whether initiation is safe …

Heart failure (HF) is a clinical syndrome with symptoms and or signs caused by a structural
and/or functional cardiac abnormality and associated with elevated natriuretic peptide levels …

Nutrition in the cardiovascular field to date has focused on improving lifestyle-related
diseases such as hypertension and diabetes from the viewpoint of secondary prevention …

Malnutrition is classified into marasmus and kwashiorkor in children. However, the clinical
significance of these aspects is unclear in adult patients with heart failure (HF). We divided …

Enhancing access to care using telehealth is a priority for improving outcomes among older
adults with heart failure, increasing quality of care, and decreasing costs. Telehealth has the …

Background Current evidence that supports palliative care interventions predominantly
focuses on individuals with cancer or hospitalized patients. However, the effectiveness of …

Background The characteristics, tolerability, and outcomes in patients with heart failure (HF)
who are treated with sacubitril/valsartan remain unclear in Japan. Methods We conducted a …

Objective Sodium-glucose cotransporter 2 (SGLT2) inhibitors have well-documented effects
in reducing hospitalization or cardiovascular mortality, while the association of SGLT2 …